EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026)

Nuria Rodriguez Salas, Juan de la Haba-Rodriguez, Ferran Ferragut Lloret, Maria Angeles Vaz Salgado, Martín Oré Arce, Ana Cardeña Gutiérrez, Carmen Beato Zambrano, Rosa María Rodríguez Alonso, Rafael López López, Jesús García-Donas Jiménez

Clinical and Translational Oncology · 27.07.2026

DOI: 10.1007/s12094-026-04520-4 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical and Translational Oncology, online erschienen am 27.07.2026. Verfasst von Nuria Rodriguez Salas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hospital La Paz, Madrid, Spain. nuria.rodriguez@salud.madrid.org. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sociedad Española de Oncología Médica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identification of molecular alterations in cancer and advances in technology have enhanced the use of molecular alterations for the diagnosis and treatment of cancer in routine clinical practice. Multi-determination platforms are now available in most Spanish hospitals. First developed in 2021, the objective of these clinical practice guidelines is to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice. Here, we provide updated guidelines, which include the most recent advancements in this area.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersMolecular platformsNext-generation sequencingPrecision medicine

Autor:innen und Institutionen

  • Department of Medical Oncology, Hospital La Paz, Madrid, Spain. nuria.rodriguez@salud.madrid.org.
  • Department of Medical Oncology, Hospital Universitario Reina Sofia, Instituto Maimonides de Investigacion Biomedica, Universidad de Córdoba, Córdoba, Spain.
  • Department of Medical Oncology, Hospital General Universitario, Ciudad Real, Spain.
  • Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Department of Medical Oncology, Hospital Marina Baixa de Villajoyosa, Alicante, Spain.
  • Department of Medical Oncology, Hospital Universitario Nuestra Señora de La Candelaria, Tenerife, Spain.

Förderung

  • Sociedad Española de Oncología Médica

Zitieren

APA

Rodriguez Salas, N., de la Haba-Rodriguez, J., Ferragut Lloret, F., Vaz Salgado, M. A., Oré Arce, M., Cardeña Gutiérrez, A., Beato Zambrano, C., Rodríguez Alonso, R. M., López López, R., & García-Donas Jiménez, J. (2026). SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026). Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04520-4

Vancouver

Rodriguez Salas N, de la Haba-Rodriguez J, Ferragut Lloret F, Vaz Salgado MA, Oré Arce M, Cardeña Gutiérrez A, et al. SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026). Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04520-4

BibTeX
@article{RodriguezSalas2026,
  author = {Rodriguez Salas, Nuria and de la Haba-Rodriguez, Juan and Ferragut Lloret, Ferran and Vaz Salgado, Maria Angeles and Oré Arce, Martín and Cardeña Gutiérrez, Ana and Beato Zambrano, Carmen and Rodríguez Alonso, Rosa María and López López, Rafael and García-Donas Jiménez, Jesús},
  title = {SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026)},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04520-4}
}
Kostenlos starten →